Israel Active

Researchers at Hadassah University Hospital have discovered that four genes generate an anti-aging effect on women who conceive naturally after age 45. The findings were the result of a genetic study of ultra-Orthodox Ashkenazi women from Mea She'arim who have at least six children.

Israel’s Can-Fite BioPharma has reported successful pre-clinical trials of CF101 for the treatment of anterior uveitis – the inflammation of the iris. An earlier trial found CF101 effective in treating posterior uveitis – inflammation of the retina. Uveitis is a common cause of blindness in the USA.

Ben Gurion University’s V-Smart drug delivery technology has been licensed to a New York biotechnology company. Lauren Sciences will develop the technology for treating Parkinson's, Alzheimer's, Amyotrophic Lateral Sclerosis (ALS / Lou Gehrig’s), and brain malignancies.

2010 figures show that only 2.2% of heart attack victims died soon afterwards. This compared to 16.2% in the USA. Lives are saved due to expanded treatment facilities plus the use of catheter angiographies, to determine the need to unblock arteries immediately on admission.

Multinational cosmetics firm L’Oreal and UNESCO have named a Weizmann Institute biologist “Europe’s top young researcher.” For her work in researching probiotics to treat disease, Dr. Naama Geva-Zatorsky will receive a two-year $40,000 postdoctoral scholarship.

Israel’s 2012 Young Nanotechnology Researcher is Professor Ze’ev Zalevsky of Bar-Ilan University. His invention - the “Opto-Phone” – can read an individual’s medical information (heartbeat, blood pressure, and blood glucose levels) remotely. A laser beam, an advanced camera and sensitive software, use nano-photonics to detect movement on the surface of the body.

Israel’s Teva Pharmaceuticals is to sell, in the US and UK, Quetiapine Fumarate tablets – the company’s version of AstraZeneca’s Seroquel schizophrenia treatment.

(Thanks to Israel21c) More details about Thrombotech’s THR-18 and how it soon could be making a significant impact on saving the lives of stroke victims. With personal wishes for a speedy recovery to the father of one our good friends.

The US Food and Drug Administration has recruited Israel’s OptiCul Diagnostics for a special project to detect the presence of bacteria on medical devices. OptiCul has developed a fast kit for the detection of bacteria without the use of reagents.